Abstract
To assess the long-term efficacy and safety of single and multiple courses of rituximab therapy in systemic sclerosis (SSc) patients with and without lung disease.
| Original language | English |
|---|---|
| Pages (from-to) | 428-436 |
| Number of pages | 9 |
| Journal | Seminars in Arthritis and Rheumatism |
| Volume | 44 |
| DOIs | |
| Publication status | Published - 2014 |
Keywords
- B cells
- CD20 depletion therapy
- Lung involvement
- Skin fibrosis
- Systemic sclerosis
Fingerprint
Dive into the research topics of 'Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver